This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Addus HomeCare Corporation (Nasdaq: ADUS) may slow down on mergers and acquisitions in the near term as it absorbs Gentiva’s personalcare business. Addus provides personalcare, home health and hospice to more than 48,500 patients across 22 states. Its personalcare revenues reached $215.4
Hospices in 2025 are laser-focused on organic growth rather than other tactics like acquisitions. Among 112 hospice professionals who responded to the 2024 Outlook Survey by Hospice News and Homecare Homebase, 60% said that expanding current locations would be the growth tactic they plan to use the most during 2025.
Hospice News explores the issues garnering growing attention in end-of-life care delivery in seven of this years hidden gem stories. Topics span trends related to program integrity, workforce development, health equity, service diversification and the keys to hospices growth strategies. Optum completed its $5.4
Addus HomeCare Corporation (Nasdaq: ADUS) has closed its $350 million acquisition of Gentiva’s personalcare business. Gentiva’s personalcare segment brings in annual revenues of close to $280.0 Notably, we will now be the largest provider of personalcare services in the state of Texas,” Allison said. “We
Many hospices in 2025 are driving to expand in the senior housing and assisted living space. million licensed beds, according to the American Health Care Association and the National Center for Assisted Living (AHCA/NCAL). Were looking at assisted living, senior living, that sort of thing, Ponder Stansel told Hospice News.
Addus Homecare (Nasdaq: ADUS) has seen steady hospice growth during the first quarter of 2025. Hospice represents 18% of Addus business, with the remainder made up by its personalcare and home health segments. When we think about hospice, we look for, on a revenue basis, a 5% to 7% range. The company saw 9.9%
Addus HomeCare Corporation (NASDAQ: ADUS) has entered into a definitive agreement to acquire Gentiva’s personalcare business for about $350 million. Gentiva’s personalcare segment brings in annual revenues of close to $280.0
Though the acquisition market has slowed down this year for home-based care companies, Addus HomeCare Corp. The most prominent home-based care transactions so far this year have involved payers seeking to acquire large providers with multiple business lines. Its hospice segment earned $53.1 million, up 12.6%
As Addus HomeCare Corp (NASDAQ: ADUS) gears up for expansion, the company is focused on ensuring its workforce can absorb the growing capacity. . Hospice operators have relied on contract nursing to stay afloat during a time of worsening labor pressures, elevated turnover and rising demand for care. in Q1 to $226.6 in February.
Addus HomeCare Corporation (Nasdaq: ADUS) is anticipating slow-churning growth across its trifecta of home-based services. The company projected evolving hospice industry dynamics over the next year. Texas-headquartered Addus provides personalcare, home health and hospice services in 23 states.
Addus HomeCare Corporation’s (NASDAQ: ADUS) is shifting its M&A strategy away from hospice deals to focus on its home health and personalcare businesses. Texas-based Addus provides personal, home health and hospicecare across 207 locations in 22 states, reaching roughly 46,500 patients annually.
Addus HomeCare Corp. NASDAQ: ADUS) is poised for further acquisitions, potentially including some hospice deals. The company is seeking to pair its clinical services with its personal business in its existing markets. Hospice revenue per day was up 3.7% Hospice revenue per day was up 3.7% The company saw 11.6%
Addus HomeCare Corporation’s (NASDAQ: ADUS) hospice segment is seeing slow but steady improvement as pandemic headwinds ease. Meanwhile, the company’s near-term acquisition sights are set more on home health than in personalcare amid potential payment shifts. In Q1 2023, Addus’ hospice segment brought in $49.08
As Addus HomeCare Corporation (NASDAQ: ADUS) sinks teeth into acquisitions, the company will be taking smaller bites when it comes to hospice deals. Addus has indicated for roughly the last year that it will orient its M&A strategy towards its home health and personalcare services, with hospice becoming less of a priority.
Strategic priorities for Texas-headquartered Addus HomeCare Corporation (NASDAQ: ADUS) continue to focus on personalcare and home health and less on hospice as the company waits for the dust to settle following its Gentiva personalcare acquisition. Addus offers personalcare, hospice and home health.
A few hospice executives have recently announced their retirement as new leaders step forward at a number of organizations. Addus president, COO retires Addus HomeCare Corporation (Nasdaq: ADUS) President and COO Brad Bickham recently announced his retirement, effective March 2026.
Addus HomeCare Corporations (Nasdaq: ADUS) purchase of Gentivas personalcare segment is bearing fruit as the company drives forward on its acquisition strategy in 2025. But labor constraints and evolving reimbursement pressures could complicate the growth of its hospice and home-based services. increase from $54.7
Ohio-based Queen City Hospice, an Addus Homecare (NASDAQ: ADUS) company, recently opened a new location in its home state. The new location in Fayetteville, Ohio, adds a central office in a rural region of the hospice’s service area that will reduce staff travel time. Centers for Medicare & Medicaid Services (CMS).
Though the number of hospice M&A deals plummeted in 2023 compared to prior years, deals are still being made, and the industry may see a rebound in 2024. Transaction volume declined in the hospice and home-based care space in 2023, following the two record-breaking prior years. This followed its $5.4 NYSE: HUM) for $2.8
The nation’s publicly traded hospice companies are primed for more acquisitions after a 2023 slump, fueled by census and growth. Transaction volume declined in the hospice and home-based care space in 2023, following the two record-breaking prior years. Case in point, VITAS Healthcare, a subsidiary of Chemed Corp.
Hospices are increasingly eying palliative care as a promising growth opportunity, prioritizing expansion in that field over other health care service lines. Survey respondents included nearly 330 hospice and palliative care industry professionals, including owners, executive leaders and managers, among others.
Thus far in 2023, hospice merger and acquisition activity has deviated from prior years. The last five years saw record-breaking multiples in the hospice space and private equity-backed platform deals were among the most common types of transactions. A number of trends have shifted. billion , which closed at the end of 2022. “The
Hospices are beginning to leverage technologies used to identify eligible patients in need to recruit and retain staff amid ongoing workforce shortages. Hospices are now applying those tools to help relieve industry-wide labor pressures. Hospices are now applying those tools to help relieve industry-wide labor pressures.
In 2022, the hospice community laid the groundwork for a transformational 2023. Centers for Medicare & Medicaid Services (CMS) developed new approaches for enforcing hospice regulations that will become effective on Jan. These trends in value-based care have even influenced the M&A market.
s (NASDAQ: AVAH) hospice and home health segments saw small jumps in the third quarter, but these lagged behind the company’s growth targets. The IPO occurred during a tumultuous era in health care, with providers across the continuum still reeling from the pandemic and worsened workforce pressures. Aveanna Healthcare Holdings, Inc.’s
Five hospice providers made Inc. They include Texas-headquartered Traditions Health, Bridge Home Health & Hospice and Healthflex Home Health & Hospice, both in California. Philadelphia-based All-American Home Care and Innovative Homecare Solutions in Illinois also appeared on the list. span the nation.
Gentiva’s recent $710 million acquisition of ProMedica’s hospice and home-based care assets bucks prevailing trends in today’s M&A market. NYSE: GS), a representative for Gentiva told Hospice News’ sister publication Skilled Nursing News. billion divestiture of Kindred at Home’s hospice and personalcare segments.
Addus HomeCare Corporation (NASDAQ: ADUS) has acquired Chicago-based Apple Home Healthcare, Ltd., The state is one of three in which Addus offers its trifecta of business lines — personalcare, home health and hospice. Since 2019, Addus has purchased seven personalcare companies and four home health and hospice agencies.
Though hospice deal volume dipped in 2022 compared to previous years, five particular transactions could paint a larger picture of where investors see value in the space. These interesting, unusual or groundbreaking deals could signal what’s to come in 2023 and help shape the hospice market’s long-term future. This was Humana Inc.’s
Addus HomeCare Corp. NASDAQ: ADUS) has reached an agreement to purchase the home health, hospice and private duty operator Tennessee Quality Care for $106 million. Tennessee Quality Care operates 17 locations serving an average of 1,800 patients daily throughout 50 of the 95 counties in its home state.
Two of the nation’s largest hospice and home-based care industry organizations are merging and have announced a combined board that will guide the transition. Recently, many of those efforts have included advocacy around program integrity within the Medicare Hospice Benefit. Lloyd, president and CEO, Delaware Hospice, Inc.
Bolstered by recent acquisitions, Addus Homecare’s (NASDAQ: ADUS) hospice segment is holding its own against labor headwinds and inflation. For example, the company’s $85 million acquisition of Illinois-based hospice provider JourneyCare Inc., The hospice segment brought in $52.074 million, up from $36.9 About 2.5%
Addus HomeCare Corp. NASDAQ: ADUS) has completed the acquisition of the home health, hospice, and private-duty company Tennessee Quality Care for an undisclosed amount. All told, Addus provides hospice, home health and personalcare to an estimated 47,500 patients annually across 203 locations in 22 states.
That path will divert more toward home health and personalcare – and less in the direction of hospice – as 2023 progresses. The company added to its clinical workforce with 80 new hires during the fourth quarter, with hospice hiring especially strong. Addus’ hospice census rose along with the company’s staffing volumes.
The pendulum of investor interest has swung hard into the hospice market in recent years, but shifts in reimbursement could steer buyers towards home health. Uncertainty earlier this year around Medicare’s proposed 2023 home health payment rates led some stakeholders to expect a swerve towards hospice. The initially proposed 4.2%
The Future Leaders Awards program is brought to you in partnership with Homecare Homebase. The program is designed to recognize up-and-coming industry members who are shaping the next decade of home health, hospicecare, senior housing, skilled nursing, and behavioral health. To see this year’s Future Leaders, visit [link].
Addus HomeCare (NASDAQ: ADUS) has gone all-in on building out its care continuum. Launched as a personalcare provider, the company in 2016 began offering hospice and home health to enhance its value proposition for payers by further reducing hospitalizations and emergency department visits. “If
Addus HomeCare Corporation (NASDAQ: ADUS) announced Wednesday that it has named a new EVP and chief development officer in Cliff Blessing, who had previously served as the EVP of corporate development for Encompass Health’s (NYSE: EHC) home health and hospice business.
Acquisitions will be crucial to Addus HomeCare Corp.’s In February Addus completed its $85 million acquisition of Illinous-based hospice provider JourneyCare Inc., The company last year acquired Armada Hospice of New Mexico and Armada Hospice of Santa Fe for $29 million. The hospice segment brought in $47.7
The Future Leaders Awards program is brought to you in partnership with Homecare Homebase. The program is designed to recognize up-and-coming industry members who are shaping the next decade of home health, hospicecare, senior housing, skilled nursing, and behavioral health. To see this year’s Future Leaders, visit [link].
The Future Leaders Awards program is brought to you in partnership with Homecare Homebase. The program is designed to recognize up-and-coming industry members who are shaping the next decade of home health, hospicecare, senior housing, skilled nursing, and behavioral health. What drew you to the hospice industry?
This annual award is based on the results of your client experience surveys. This annual award is based on the results of your client experience surveys.
This annual award is based on the results of your caregiver experience surveys. This annual award is based on the results of your caregiver experience surveys.
For Immediate Release December 21, 2023 The National Association for Home Care & Hospice (NAHC) and the National Hospice & Palliative Care Organization (NHPCO) jointly announced today that they have developed a proposed slate of Transition Board of Directors and officers for 2024.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content